Patents by Inventor Eugene Hur

Eugene Hur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COSMETIC COMPOSITION FOR IMPROVING SKIN CONDITIONS COMPRISING FUSION PROTEIN INCLUDING SKIN PENETRATION ENHANCING PEPTIDE
    Publication number: 20200165312
    Abstract: Provided is a cosmetic composition for improving skin conditions including a fusion protein containing a skin penetration enhancing peptide, more particularly, a fusion protein in which PDGFa is bound to the skin penetration enhancing peptide, and a cosmetic composition for improving skin conditions, a functional cosmetic product for improving skin conditions, a cosmetic composition for preventing and treating alopecia, and a quasi-drug composition each including the fusion protein.
    Type: Application
    Filed: June 28, 2018
    Publication date: May 28, 2020
    Applicant: LG HOUSEHOLD & HEALTH CARE LTD.
    Inventors: Jin Hyun KIM, Jaeyoon KIM, Ho Song CHO, Ji Seon YOON, Sanghwa LEE, Nae Gyu KANG, Hyun Jong LEE, Seol Hoon LEE, Eugene HUR, Taeyoon KIM
  • Inhibitors for androgen antagonist refractory prostate cancer
    Publication number: 20070087352
    Abstract: The present invention relates to methods and antagonist compounds for modulating androgen receptor activity. The invention includes a method for identifying molecules that bind to a coactivator binding site of a receptor in the androgen receptor family. Also included is a cocrystal of an androgen receptor ligand binding domain complexed with a ligand and a coactivator. The invention further includes a method for inhibiting androgen receptor activity in a mammal, thereby facilitating treatment of diseases such as prostate cancer.
    Type: Application
    Filed: November 6, 2003
    Publication date: April 19, 2007
    Inventors: Robert Fletterick, Eva Estebanez-Perpina, Eugene Hur, Samuel Pfaff, Benjamin Buehrer
  • Inhibitors for androgen antagonist refractory prostate cancer
    Publication number: 20050202440
    Abstract: The present invention relates to methods and antagonist compounds for modulating androgen receptor activity. The invention includes a method for identifying molecules that bind to a coactivator binding site of a receptor in the androgen receptor family. Also included is a cocrystal of an androgen receptor ligand binding domain complexed with a ligand and a coactivator. The invention further includes a method for inhibiting androgen receptor activity in a mammal, thereby facilitating treatment of diseases such as prostate cancer.
    Type: Application
    Filed: November 6, 2003
    Publication date: September 15, 2005
    Inventors: Robert Fletterick, Eva Estebanez-Perpina, Eugene Hur, Samuel Pfaff, Benjamin Buehrer